Related Experiment Videos
Mutagenicity of actinomycin D in mammalian cells due to clastogenic effects
D M DeMarini1, K H Brock, C L Doerr
1Genetic Toxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711.
Mutation Research
|October 1, 1987
Abstract:
Actinomycin D was clastogenic and mutagenic in L5178Y/TK +/- -3.7.2C mouse lymphoma cells. The majority of the mutants were small colonies, indicating that actinomycin D acts primarily by a clastogenic mechanism.
Insights
Actinomycin D causes genetic damage in mouse lymphoma cells, primarily through clastogenic mechanisms. Most induced mutations resulted in small colonies, confirming its DNA-damaging effects.
Area of Science:
- Genetics
- Toxicology
- Cell Biology
Background:
- Actinomycin D is a known chemotherapeutic agent with potential genotoxic effects.
- Understanding the precise mechanisms of DNA damage induced by Actinomycin D is crucial for its clinical application and safety assessment.
Purpose of the Study:
- To investigate the clastogenic and mutagenic potential of Actinomycin D in a mammalian cell line.
- To elucidate the primary mechanism of genetic damage induced by Actinomycin D.
Main Methods:
- Utilizing the L5178Y/TK+/- mouse lymphoma cell assay.
- Treating cells with Actinomycin D and analyzing mutant colony sizes.
Main Results:
- Actinomycin D demonstrated both clastogenic and mutagenic activity in L5178Y/TK+/- cells.
- The majority of induced mutants formed small colonies, indicative of significant chromosomal damage.
Conclusions:
- Actinomycin D primarily induces genetic mutations through clastogenic mechanisms (chromosomal breakage).
- The findings highlight the DNA-damaging properties of Actinomycin D, relevant to its use in cancer therapy and genotoxicity studies.